LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 36.73 | 84.90 | 1 | 3254 | 0.0003 | -0.5701 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 36.73 | 84.90 | 721 | 3254 | 0.2216 | 0.5018 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 36.73 | 84.90 | 199 | 3254 | 0.0612 | 0.1758 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 36.73 | 84.90 | 2712 | 3254 | 0.8334 | 0.9319 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 38.43 | 84.90 | 1 | 3459 | 0.0003 | -0.5641 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 38.43 | 84.90 | 781 | 3459 | 0.2258 | 0.5142 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 38.43 | 84.90 | 224 | 3459 | 0.0647 | 0.1989 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 38.43 | 84.90 | 2901 | 3459 | 0.8385 | 0.9352 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 40.14 | 84.90 | 1 | 3682 | 0.0003 | -0.5581 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 40.14 | 84.90 | 926 | 3682 | 0.2515 | 0.5517 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 40.14 | 84.90 | 252 | 3682 | 0.0684 | 0.2215 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 40.14 | 84.90 | 3211 | 3682 | 0.8721 | 0.9503 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 41.84 | 84.90 | 1 | 4003 | 0.0002 | -0.5502 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 41.84 | 84.90 | 1062 | 4003 | 0.2653 | 0.5753 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 41.84 | 84.90 | 259 | 4003 | 0.0647 | 0.2222 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 41.84 | 84.90 | 3397 | 4003 | 0.8486 | 0.9418 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 43.55 | 84.90 | 1 | 4287 | 0.0002 | -0.5439 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 43.55 | 84.90 | 1232 | 4287 | 0.2873 | 0.6044 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 43.55 | 84.90 | 310 | 4287 | 0.0723 | 0.2572 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 43.55 | 84.90 | 3660 | 4287 | 0.8536 | 0.9448 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 45.25 | 84.90 | 1 | 4539 | 0.0002 | -0.5387 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 45.25 | 84.90 | 1382 | 4539 | 0.3044 | 0.6258 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 45.25 | 84.90 | 332 | 4539 | 0.0731 | 0.2681 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 45.25 | 84.90 | 3932 | 4539 | 0.8661 | 0.9505 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 46.95 | 84.90 | 2 | 4952 | 0.0004 | -0.4722 | MN20160318_Q02 | H17 |